Evidence map›Paper›PMID 37370804›Full record

ArticleCancers2023

Implementation of Nurse Navigation Improves Rate of Molecular Tumor Testing for Ovarian Cancer in a Gynecologic Oncology Practice.

Taylor A Rives, Heather Pavlik, Ning Li, Lien Qasrawi, Donglin Yan, Justine Pickarski, Charles S Dietrich, Rachel W Miller, Frederick R Ueland, Jill M Kolesar

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06436157 (Genetic Testing Uptake Through an Enhanced Oncology Nurse-Led Intervention in Patients With Solid Tumors), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06436157 narecruitingnot on this mapstarted 2024, after this paper: background citation

Genetic Testing Uptake Through an Enhanced Oncology Nurse-Led Intervention in Patients With Solid Tumors (GENESIS): A Pilot Study

TypeinterventionalSponsorUniversity of California, DavisRan2024 to 2025Enrolled60ConditionsSolid Tumor, AdultArmsEnhanced education, Usual care education
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Taylor A RivesDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0003-1084-6678
Heather PavlikDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY 40536, USA.
Ning LiDepartment of Biostatistics, College of Public Health, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0002-9383-7381
Lien QasrawiCollege of Pharmacy, University of Kentucky, Lexington, KY 40536, USA.
Donglin YanDepartment of Biostatistics, College of Public Health, University of Kentucky, Lexington, KY 40536, USA.
Justine PickarskiMarkey Cancer Center, University of Kentucky, Lexington, KY 40536, USA.
Charles S DietrichDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0002-9796-5022
Rachel W MillerDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY 40536, USA.
Frederick R UelandDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY 40536, USA.
Jill M KolesarDivision of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY 40536, USA.ORCID 0000-0003-1802-6439

Funding

University of Kentucky Markey Cancer Center – Cancer Center Support GrantP30CA177558 · UNIVERSITY OF KENTUCKY · 2025 to 2025
$2.8M
NCI NIH HHS P30CA177558
6 · The paper itself

Abstract

purposeThe purpose of this study was to assess the impact of implementing a Nurse Navigator (NN) to improve the rate and timeliness of molecular tumor testing.

methodsThis is an evaluation of the impact of education sessions, consensus building, and NN implementation for molecular tumor testing in patients with epithelial ovarian cancer. The NNs' responsibilities included attending tumor boards and ensuring Next Generation Sequencing (NGS) is ordered, reviewed, and coordinated for appropriate patients.

resultsNNs significantly improved NGS testing rates from 35.29% to 77.27%,

conclusionNNs significantly improved somatic tumor testing rates and timeliness for patients with ovarian cancer. Discontinuing TPT in favor of NGS revealed a higher rate of actionable tumor mutations that would have been missed with TPT alone.

Indexed as

germline testingmolecular tumor testingnext generation sequencingnurse navigationovarian cancersomatic tumor testing

Identifiers

PMID37370804
PMCPMC10296686

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.